Fareon Device for Cognitive Impairment

DP
Overseen ByDavid Putrino, PhD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Icahn School of Medicine at Mount Sinai
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new device called Fareon, designed to assist individuals with memory and thinking issues due to conditions like Long COVID, brain injuries, or Alzheimer's. The main goal is to determine if using this device at home is safe and practical for those with these cognitive challenges. Ideal participants have mild memory problems related to one of these conditions and are comfortable with either virtual or in-person visits. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research and potentially benefit from an innovative device.

Do I have to stop taking my current medications for the trial?

The trial does not specify if you need to stop taking your current medications, but if you've changed your anti-depressant or other psychoactive medication in the last 90 days, you cannot participate.

What prior data suggests that the Fareon device is safe for cognitive impairment?

Research has shown that treatments using electromagnetic fields (EMFs), such as the Fareon device, can be applied to the brain and may aid in addressing thinking and memory problems. Studies have found that these treatments are usually well-tolerated, with most individuals experiencing only mild or few side effects.

Although detailed safety information for the Fareon device is not yet available, similar devices using the same technology have been tested and have not shown significant harmful effects. This suggests potential safety for users. However, as this trial is in the early stages, further research is necessary to fully confirm these findings.12345

Why are researchers excited about this trial?

The Fareon device is unique because it offers a non-drug approach to treating cognitive impairment associated with conditions like acquired brain injury, Long COVID, and Alzheimer's disease. Unlike traditional treatments that often rely on medications to manage symptoms, the Fareon device uses a novel technology aimed at directly stimulating brain activity to improve cognitive function. Researchers are excited about its potential to provide a safer and possibly more effective alternative without the side effects associated with pharmaceuticals, offering new hope to patients with various neurodegenerative conditions.

What evidence suggests that the Fareon device is effective for cognitive impairment?

Research has shown that the Fareon device, used by participants in this trial, employs a new method called microtesla magnetic therapy (MMT) to treat cognitive problems. Early results suggest this method might improve thinking and memory in individuals with conditions like Long COVID and brain injuries. Similar treatments have benefited brain injury patients. Fareon's method is noninvasive, meaning it doesn't involve surgery or entering the body, which many patients find appealing. While researchers continue to study the device, its potential to address various thinking and memory issues is under close observation.12678

Who Is on the Research Team?

DP

David Putrino, PhD

Principal Investigator

Icahn School of Medicine at Mount Sinai

Are You a Good Fit for This Trial?

This trial is for people aged 16 or older who speak English and have mild memory or thinking problems linked to conditions like brain injury, Long COVID, chronic fatigue syndrome (ME/CFS), or Alzheimer's. Participants must be able to consent (or have a guardian do so) and attend study visits online or in person.

Inclusion Criteria

* Willing and able to attend all study visits virtually or in person
* English Speaking
My sex or gender does not affect my eligibility.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo at-home MMT treatment for cognitive dysfunction

12 weeks
At-home sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks
Assessments at Week 12 and Week 16

What Are the Treatments Tested in This Trial?

Interventions

  • Fareon device

Trial Overview

The study tests the safety and practicality of using the Fareon device—a home-based treatment—for people with cognitive issues from various brain-related conditions. Researchers will monitor how safe it is and gather early data on its effects.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Fareon DeviceExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Icahn School of Medicine at Mount Sinai

Lead Sponsor

Trials
933
Recruited
579,000+

Citations

Study Details | NCT07600320 | Fareon Open Label Device ...

The purpose of this study is to assess the safety and feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to acquired ...

Fareon Open Label Device Clinical Trial - ClinicalTrials.Veeva

The purpose of this study is to assess the safety and feasibility of an at-home MMT treatment in patients with cognitive dysfunction related ...

Humanity Neurotech Device Clinical Trial in Adults ...

The purpose of this study is to assess the feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to PASC.

Fareon, Inc.

Fareon, Inc., a Public Benefit Corporation, has developed a new noninvasive approach to treating cognitive impairment related to Long COVID.

New magnetic therapy could transform treatment of ...

The new research focuses on a novel approach developed by Fareon called microtesla magnetic therapy or MMT. The research team deployed very ...

Fareon Open Label Device Clinical Trial | NCT07600320

The purpose of this study is to assess the safety and feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to acquired brain ...

Transcranial microtesla magnetic fields suppress ... - PMC

Biophysical interventions using electromagnetic fields (EMFs) can be delivered transcranially to both superficial and deep brain structures, ...

Humanity Neurotech Device Clinical Trial in Adults With Long

The purpose of this study is to assess the feasibility of an at-home MMT treatment inpatients with cognitive dysfunction related to PASC, and to collect.